Rayner launches world’s first spiral IOL in Brazil
Posted on 27/06/2025
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that its RayOne Galaxy and RayOne Galaxy Toric intraocular lenses are now available in Brazil.
RayOne Galaxy, which saw a full commercial release in January 2025 following a highly successful multicenter study, sets a new standard for what surgeons can offer their premium lens replacement patients. Developed in collaboration with a leading Brazilian surgeon using a proprietary AI engine, its unique non-diffractive spiral optic delivers a smooth and continuous full range of vision with minimised dysphotopsia and 0% loss of transmitted light.*
This milestone marks the beginning of an exciting journey with RayOne Galaxy for Rayner in Brazil, enabling the organization to continue driving its focus on optimizing visual outcomes for surgeons and their patients around the world.
Dr. Gustavo Huning said “I’m honored to have been chosen as the pioneer for the first Galaxy IOL implantation in Brazil. I’ve been following with great interest the growing adoption of this lens as a first choice among many colleagues around the world. The approval by Brazilian regulatory authorities fills us with excitement and brings the state of the art in optical physics into the surgeon’s toolbox. I’m eager to assess its performance firsthand and explore the potential benefits Galaxy may offer my patients.”
Prof. João Marcelo Lyra, Galaxy Co-Inventor, commented “As a proud Brazilian surgeon, I’m thrilled about the availability of Galaxy in its country of origin. Since launching earlier this year, the response from surgeons and patients around the world has been phenomenal and so I’m excited to finally offer this groundbreaking technology to my own patients, which is an elegant fusion of optics, AI, and neuroscience.”
References:
*Rayner 2025. Data on file.
About Rayner:
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley in 1949, Rayner has had the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2025 Rayner Group, all rights reserved. ‘Rayner’, ‘RayOne’ and ‘Galaxy’ are proprietary marks of the Rayner Group. All other trademarks are property of their respective owners.
Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ | EC 2025-62